Patient-directed strategies to assess the quality use of statins using a novel trial design.

Not Applicable

• Conditions: Cardiovascular disease; Public Health - Health promotion/education; Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12620000221954
• Lead Sponsor: The George Institute for Global Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-02-24
• Last Update Posted: 3 March 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 12000

Inclusion Criteria

•Had 1 or more statin (defined as atorvastatin, fluvastatin, pravastatin, simvastatin or rosuvastatin) dispensed (ascertained based on PBS data) on or after the time of 45 and Up study recruitment and

•Discontinued statin use (defined as no statin dispensed for 3 or more months prior to the end date of the PBS data available within the 45 and Up study)

Exclusion Criteria

Self-reported or recorded history of known contraindications to statins

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Statin re-initiation in the first 6 months after the letter is sent<br>Study outcomes will be ascertained using existing data linkage to administrative data sources including Pharmaceutical Benefits Scheme (PBS) and Medicare Benefits Schedule (MBS) data.<br>[In the first 6 months after the letter is sent<br>]

Secondary Outcome Measures

Name	Time	Method
Proportion of patients with 1 or more GP visit within first 6 months after the letter is sent. This outcome will be assessed using Medicare Benefits Schedule linked data.<br>[Over 6 months after the letter is sent<br>]